SCHEMBL28164437

SCHEMBL28164437

O=CNc1cccc2cc[nH]c12

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NR3C1 P04150 1/20 0.56
▸ PGR P06401 1/20 0.56
▸ NR3C2 P08235 1/20 0.56
▸ AR P10275 1/20 0.56
▸ AHR P35869 1/20 0.46
▸ BACE1 P56817 1/20 0.45
▸ KEAP1 Q14145 1/20 0.44
▸ PDPK1 O15530 1/20 0.43
▸ BCHE P06276 3/20 0.41
▸ TRPV1 Q8NER1 1/20 0.39
▸ EGFR P00533 1/20 0.38
▸ GRM5 P41594 1/20 0.36
▸ TSHR P16473 1/20 0.36
▸ ATR Q13535 1/20 0.36
▸ PTPN11 Q06124 1/20 0.36
▸ MEN1 O00255 1/20 0.35
▸ NPC1 O15118 1/20 0.35
▸ ALDH1A1 P00352 1/20 0.35
▸ POLB P06746 1/20 0.35
▸ MAPT P10636 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28940859 0.81 NR3C1 (0.51) NR3C1PGRNR3C2ARAHR
SCHEMBL25350212 0.75 AHR (0.39) NR3C1PGRNR3C2ARAHR
SCHEMBL25593878 0.75 PTPRC (0.39) NR3C1PGRNR3C2ARAHR
SCHEMBL13085560 0.75 NR3C1 (0.61) NR3C1PGRNR3C2ARAHR
SCHEMBL19187519 0.74 NR3C1 (0.56) NR3C1PGRNR3C2ARAHR
SCHEMBL27799452 0.74 CYP2A6 (0.38) NR3C1PGRNR3C2ARAHR
SCHEMBL28783302 0.74 IKBKB (0.51) NR3C1PGRNR3C2ARTSHR
SCHEMBL27698981 0.73 KEAP1 (0.56) NR3C1PGRNR3C2ARAHR
SCHEMBL30026274 0.71 PDPK1 (0.57) NR3C1PGRNR3C2ARAHR
SCHEMBL6091339 0.71 NR3C1 (0.57) NR3C1PGRNR3C2ARBACE1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110511209-A It can be used as the indole carboxamides compound of kinase inhibitor BRISTOL MYERS SQUIBB CO 2019-11-29 — — CN claimed
CN-105530932-B Primary formamide as BTK inhibitor 艾伯维公司 2019-09-27 — — CN claimed
CN-105492444-B Tricyclic pyridine-carboxamide derivatives as ROCK inhibitors 百时美施贵宝公司 2018-09-07 — — CN claimed
CN-107841532-A Screen the method for anti-breast cancer transfer compounds and the application of related compound 清华大学 2018-03-27 — — CN claimed
CN-107108583-A Indole carboxamide compounds useful as kinase inhibitors 百时美施贵宝公司 2017-08-29 — — CN claimed
CN-110511209-A It can be used as the indole carboxamides compound of kinase inhibitor BRISTOL MYERS SQUIBB CO 2019-11-29 — — CN disclosed
CN-105530932-B Primary formamide as BTK inhibitor 艾伯维公司 2019-09-27 — — CN disclosed
CN-109923107-A The method for being used to prepare indole carboxamides compound 百时美施贵宝公司 2019-06-21 — — CN disclosed
CN-109923107-A The method for being used to prepare indole carboxamides compound 百时美施贵宝公司 2019-06-21 — — CN disclosed
CN-108558871-A Novel tricyclic compound as anticancer agent 百时美施贵宝公司 2018-09-21 — — CN disclosed
CN-105492444-B Tricyclic pyridine-carboxamide derivatives as ROCK inhibitors 百时美施贵宝公司 2018-09-07 — — CN disclosed
CN-106029663-B Tricyclic compounds as anticancer agents 百时美施贵宝公司 2018-06-01 — — CN disclosed
CN-104144931-B Pyrimido [4,5 b] indole derivatives and its application in the amplification of candidate stem cell 蒙特利尔大学 2018-04-10 — — CN disclosed
CN-107841532-A Screen the method for anti-breast cancer transfer compounds and the application of related compound 清华大学 2018-03-27 — — CN disclosed
CN-107428733-A CD38 inhibitor and treatment method 葛兰素史克知识产权第二有限公司 2017-12-01 — — CN disclosed
CN-107108583-A Indole carboxamide compounds useful as kinase inhibitors 百时美施贵宝公司 2017-08-29 — — CN disclosed
Send feedback